NRNP 6552 Common Gynecologic Conditions, Part 1
Week 4: Case Study 1- Episodic/Focused SOAP Note
Patient Information:
Initials: T.S Age: 58 Sex: Female Race: African American
S.
CC (chief complaint): “brown discharge to pink spotting”
HPI: T.S., a 58-year-old African American woman, comes into the clinic complaining of brown discharge to pink spotting for many days last week. The patient’s medical record indicates a noteworthy medical history of type 2 diabetes, which has been partially managed through the use of glipizide and metformin, as evidenced by a recent A1C reading of 7.5. She has a nulliparous obstetric history, indicating that she has never experienced a pregnancy. The patient is current with regards to mammograms and underwent a colonoscopy one year prior, with results indicating no abnormalities. The patient’s pap smear history is within normal limits, with her most recent pap smear conducted two years ago indicating a negative for intraepithelial lesion or malignancy (NILM) result. The results indicate a lack of HPV presence, the presence of atrophic changes, and the absence of endocervical cells.
Location: vaginal
Onset: last week
Character: brown discharge to pink spotting
Associated signs and symptoms: none
Timing: none
Exacerbating/relieving factors: none
Severity: 6/10 pain scale
Current Medications: Glipizide 5 mg once a day and metformin 500 mg twice daily
Allergies: No known sensitivities to substances, foods, or environments.
PMHx:
Past Medical History: type 2 diabetes which is well managed with medication
Immunizations: Vaccination records are current.
Soc & Substance Hx: The patient is married but has never given birth and has no children. She shares a two-story, three-bedroom single-family home with her hubby. prohibits using tobacco, using e-cigarettes, vaping, or being around others who do. denies engaging in illicit or recreational drug use. denies having a drink. She says she is now a banker. She professes to be a devout Christian and puts a lot of importance on her spiritual health. She says she has a huge network of family, friends, and churchgoers. She eats three meals a day and says she tries her hardest. She naps for six to eight hours. She usually works out by taking the dog for a walk in the evening.
Fam Hx: Her father has diabetes and is 83 years old. Two years ago, her mother’s cervical cancer took her life.
Surgical Hx: None
Mental Hx: denies sadness or anxiety. denies having ever used self-harm or had suicidal or homicidal thoughts.
Violence Hx: denies any safety worries or concerns
Reproductive Hx: GYN History: LMP eight years ago; most recent Pap test was two years ago; results were WNL; one partner; and no use of birth control; straight. OB History: Gravida: 0 Para: 0
ROS:
GENERAL: The patient seemed healthy, and active, and denied having gained or lost weight.
HEENT: Eyes: denies any loss of vision, double vision, impaired vision, or yellow sclera. Denies hearing loss, sniffles, congested nose, runny nose, or hoarseness.
SKIN: denies having a rash or irritation.
CARDIOVASCULAR: denies feeling pressure, pain, or discomfort in the chest. No edema or palpitations.
RESPIRATORY: denies having a cough, sputum, or shortness of breath.
GASTROINTESTINAL: denies having anorexia, motion sickness, or diarrhea. neither blood nor stomach discomfort.
NEUROLOGICAL: denies experiencing headaches, vertigo, syncope, paralysis, ataxia, or tingling in the extremities. No modification to bladder or bowel control.
MUSCULOSKELETAL: denies experiencing stiffness, joint discomfort, back pain, or muscular pain.
HEMATOLOGIC: denies bruising, bleeding, or anemia.
LYMPHATICS: denies having larger nodes. denies having had a splenectomy.
PSYCHIATRIC: denies having a history of anxiety or depression.
ENDOCRINOLOGIC: reports a type 2 diabetes history. denies having a cold or heat sensitivity or sweating. No polydipsia or polyuria.
GENITOURINARY/REPRODUCTIVE: complaints of brown discharge to pink spots last week, lasting for many days. LMP eight years back, last Pap test two years ago, resulting in WNL, one partner, no birth control use, heterosexual. OB History: Gravida: 0 Para: 0
ALLERGIES: denies having ever had rhinitis, hives, asthma, or eczema.
O.
Physical exam:
Vital signs: Temperature: 98.1°F, blood pressure: 140/88, pulse: 82, and respirations: 12. She is 272 pounds and 5’6″. (BMI 43.90).
Focused exam:
General: focused and awake. seemed to be well-groomed. The patient does not seem to be experiencing any immediate discomfort.
Abdomen: soft, overweight, and bowel sound-positive
VVBSU: observed brown discharge,
Cervix: No cervical motion pain and brown blood were seen originating from the os
Uterus: being unable to evaluate owing to the physical habit
Adnexa: owing to bodily habit, impossible to evaluate
Diagnostic results: A1C last 7.5. Her Pap history is normal, and her most recent Pap revealed a NILM two years ago. Atrophic alterations, no endocervical cells, and HPV negative.
A.
Primary and Differential Diagnoses
- Endometrial or Vaginal Atrophy: Brown spotting after menopause, as seen by the patient, is often an indication that blood has mixed with the discharge. According to studies, postmenopausal women often have vaginal atrophy, which may cause brown spotting and itching (Nappi et al., 2020).
- Endometrial polyps: Brown discharge seen before and after menstruation is another sign of polyps (Tanos, 2019). Painless polyps do not exist.
- UTI: Diabetic patients, like the one mentioned above, often get UTIs. In addition to the acute UTI symptoms, persistent UTIs may result in spotting, blood in the urine, or discharge (Wasserman & Rubin, 2023).
Primary diagnosis: Endometrial or Vaginal Atrophy
Additional Questions:
- What additional symptoms do you manifest besides the transition from pink discharge to brown spotting? This inquiry will facilitate the acquisition of additional data to bolster the primary diagnosis. Elia et al. (2019) have identified several symptoms that are associated with the condition, including vaginal dryness, itchiness, burning during urination, and recurrent urinary tract infections.
- What was the date of your most recent menstrual cycle? The inquiry in question is intended to ascertain whether the symptoms exhibited by the patient are attributable to menopause, as posited by Elia et al. (2019).
- Have you engaged in sexual activity recently? This inquiry will aid in ascertaining whether the individual’s symptoms are attributable to a sexually transmitted infection/disease.
The lining of the patient’s vagina becomes drier and thinner in vaginal atrophy. To corroborate this diagnosis, the inquiries will concentrate on symptoms like itchiness, burning, and discomfort during sex, among others (Nappi et al., 2020). Urinary tract issues such as urinary incontinence and UTIs are also a part of this illness.
Diagnostic tests: A Pap test, ultrasound, urine sample, vaginal pH (acid test), and testing for vaginal infection will all be required to establish the main diagnosis and exclude the differentials (Nappi et al., 2019).
Treatment options: Only dehydroepiandrosterone (DHEA) and estrogen therapy are hormone treatments for vaginal atrophy (Pinkerton, 2021).
Health Promotion: Regular sexual activity improves vaginal tissue blood flow, which helps prevent vaginal atrophy (Nappi et al., 2019).
Patient Education: admonish the patient to stay away from vaginal irritants including douching, dye, shampoo, and cologne (Nappi et al., 2019).
Referrals: The patient needs to see a gynecologist for further assessment and treatment.
Follow-up: After two weeks, the patient must return to the clinic for an assessment of the effectiveness of the therapy.
Reflection: The material presented for the assigned case study is rather scant, supporting the main vaginal atrophy diagnosis. Brown spotting is a frequent symptom of menopause and may be brought on by several medical issues. However, DHEA is the most effective kind of therapy if the patient’s vaginal atrophy is proven (Pinkerton, 2021). To improve the patient’s general health and well-being, it is also important to encourage her to consume a good diet and exercise often. One of the key preventative methods for vaginal atrophy has also been suggested: regular sexual activity.
References
Elia, D., Gambacciani, M., Berreni, N., Bohbot, J. M., Druckmann, R., Geoffrion, H., Haab, F., Heiss, N., Rygaloff, N., & Russo, E. (2019). Genitourinary syndrome of menopause (GSM) and laser VEL: a review. Hormone Molecular Biology and Clinical Investigation, 0(0). https://doi.org/10.1515/hmbci-2019-0024
Nappi, R. E., Di Carlo, C., Cucinella, L., & Gambacciani, M. (2020). Viewing symptoms associated with Vulvovaginal Atrophy (VVA)/Genitourinary syndrome of menopause (GSM) through the estro-androgenic lens – Cluster analysis of a web-based Italian survey among women over 40. Maturitas, 140, 72–79. https://doi.org/10.1016/j.maturitas.2020.06.018
Nappi, R. E., Martini, E., Cucinella, L., Martella, S., Tiranini, L., Inzoli, A., Brambilla, E., Bosoni, D., Cassani, C., & Gardella, B. (2019). Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women. Frontiers in Endocrinology, 10. https://doi.org/10.3389/fendo.2019.00561
Pinkerton, J. V. (2021). Selective Estrogen Receptor Modulators in Gynecology Practice. Clinical Obstetrics & Gynecology, 64(4), 803–812. https://doi.org/10.1097/grf.0000000000000647
Tanos, V. (2019). Management of endometrial polyps. Women Health Care and Issues, 2(1), 01–07. https://doi.org/10.31579/2642-9756/004
Wasserman, M. C., & Rubin, R. S. (2023). Urologic view in the management of genitourinary syndrome of menopause. Climacteric, 1–7. https://doi.org/10.1080/13697137.2023.2202811
CLICK HERE TO ORDER A PLAGIARISM-FREE PAPER
COMMON GYNECOLOGIC CONDITIONS, PART 1
Case studies provide the opportunity to simulate realistic scenarios involving patients presenting with various health problems or symptoms. Such case studies enable nurse learners to apply concepts, lessons, and critical thinking to interviewing, screening, and diagnostic approaches, as well as to the development of treatment plans.
For this Case Study Discussion, you will once again review a case study scenario to obtain information related to a comprehensive well-woman exam and determine differential diagnoses, diagnostics, and develop treatment and management plans.
RESOURCES
Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources.
LEARNING RESOURCES
Required Readings
- Schuiling, K. D., & Likis, F. E. (2022). Gynecologic health care (4th ed.). Jones and Bartlett Learning.
- Chapter 17, “Breast Conditions” (pp. 337-349)
- Chapter 18, “Alterations in Sexual Function” (pp. 353-364)
- Chapter 20, “Infertility” (pp. 383-398)
- Chapter 21, “Gynecologic Infections” (pp. 401-432)
- Chapter 22, “Sexually Transmitted Infections” (pp. 437-466)
- Reproductive Health Access Project (2020). Your birth control choicesLinks to an external site.. https://www.reproductiveaccess.org/wp-content/uploads/2014/06/contra_choices.pdf
- Office of Women’s Health: Womenshealth.gov. (2017). Birth control methodsLinks to an external site.. https://www.womenshealth.gov/a-z-topics/birth-control-methods
CLINICAL GUIDELINE RESOURCES
As you review the following resources, you may want to include a topic in the search area to gather detailed information (e.g., breast cancer screening guidelines; for CDC – zika in pregnancy).
- American Cancer Society, Inc. (ACS). (2020). Information and Resources about for Cancer: Breast, Colon, Lung, Prostate, SkinLinks to an external site.. https://www.cancer.org/
- American College of Obstetricians and Gynecologists (ACOG)Links to an external site.. (2020). https://www.acog.org/
- American Nurses Association (ANA). (n.d.). Lead the profession to shape the future of nursing and health careLinks to an external site.. https://www.nursingworld.org/
- Centers for Disease Control and Prevention. (CDC)Links to an external site.. (n.d.). https://www.cdc.gov/
- HealthyPeople 2030. (2020). Healthy People 2030 FrameworkLinks to an external site.. https://www.healthypeople.gov/2020/About-Healthy-People/Development-Healthy-People-2030/Framework
- The American Association of Nurse Practitioners (AANP)Links to an external site.. (2020). https://www.aanp.org/
- Document: Focused SOAP Note Template Download Focused SOAP Note Template(Word document)
Optional Resources
Note: In Weeks 1-10, these resources are optional for your review. In Week 11, you will be required to review each of the PowerPoint slides from the text Gynecologic Health Care (4th ed.).
- Chapter 17, “Breast Conditions Download Breast Conditions”
- Chapter 18, “Alterations in Sexual Function Download Alterations in Sexual Function”
- Chapter 20, “Infertility Download Infertility”
- Chapter 21, “Gynecologic Infections Download Gynecologic Infections”
- Chapter 22, “Sexually Transmitted Infections Download Sexually Transmitted Infections”
To prepare:
- By Day 1 of this week, you will be assigned to a specific case study scenario for this Discussion. Please see the “Course Announcements” section of the classroom for your assignment from your Instructor.
- Review the Learning Resources for this week and specifically review the clinical guideline resources specific to your assigned case study.
- Use the Focused SOAP Note Template found in the Learning Resources to support your Discussion. Complete a FOCUSED SOAP note and critically analyze this and focus your attention on the diagnostic tests. Please post your FOCUSED SOAP note. This information will help you develop your differential diagnosis and additional questions
Case Study 1
Thelma Smith is a 58-year-old African American female who presents to the office with the complaint of brown discharge to pink spotting for several days last week. Her medical history is remarkable for type 2 diabetes somewhat controlled with glipizide and metformin (last A1C 7.5). She is a G0P0, having never been able to get pregnant. She is up to date with mammograms and has had a colonoscopy 1 year ago, all normal. Her pap history is normal with her last pap 2 years ago reported an NILM HPV negative, atrophic changes, no endocervical cells noted.
Vital signs temperature 98.1 BP 140/88, pulse 82, respirations 12. She is 5’6” and 272 lbs. (BMI 43.90). Focused exam:
- Abdomen: soft, obese, + BS
- VVBSU: brown discharge noted,
- Cervix: brown blood noted coming from os, no cervical motion tenderness
- Uterus: unable to assess due to body habitus
- Adnexa: unable to assess due to body habitus
BY DAY 3
Please post your FOCUSED SOAP NOTE and post your primary diagnosis. Include the additional questions (additional questions ONLY related to the HPI/CC) you would ask the patient and explain your reasons for asking the additional questions. Then, explain the types of symptoms you would ask. Be specific and provide examples. (Note: When asking questions, consider sociocultural factors that might influence your question decisions.)
Based on the preemptive diagnosis, explain which treatment options and diagnostic tests you might recommend. Use your Learning Resources and/or evidence from the literature to support your recommendations. Your primary diagnosis, additional questions, and types of symptoms are what this assignment and grading is focused on. Your critical thinking for this assignment
Read a selection of your colleagues’ responses.
BY DAY 6
Respond to at least two of your colleagues’ posts on two different days and explain how you might think differently about the types of diagnostic tests you would recommend and explain your reasoning. Use your Learning Resources and/or evidence from the literature to support your position.
Note: For this Discussion, you are required to complete your initial post before you will be able to view and respond to your colleagues’ postings. Begin by clicking on the Reply button to complete your initial post. Remember, once you click on Post Reply, you cannot delete or edit your own posts and you cannot post anonymously. Please check your post carefully before clicking on Post Reply!
NRNP_6552_Week4_Case_Study_Discussion_Rubric
| Criteria | Ratings | Pts | ||||
|---|---|---|---|---|---|---|
| This criterion is linked to a Learning OutcomeMain Posting:Response to the case study discussion questions includes appropriate diagnoses with explanations of appropriate diagnostic tests and treatment options as directed, is based on evidence-based research where appropriate, and is incorporates syntheses representative of knowledge gained from the course readings for the module and current credible sources. |
|
44 pts | ||||
| This criterion is linked to a Learning OutcomeMain Posting:Writing |
|
6 pts | ||||
| This criterion is linked to a Learning OutcomeMain Posting:Timely and full participation |
|
10 pts | ||||
| This criterion is linked to a Learning OutcomeFirst Response:Post to colleague’s main post that is reflective and justified with credible sources. |
|
9 pts | ||||
| This criterion is linked to a Learning OutcomeFirst Response: Writing |
|
6 pts | ||||
| This criterion is linked to a Learning OutcomeFirst Response:Timely and full participation |
|
5 pts | ||||
| This criterion is linked to a Learning OutcomeSecond Response:Post to colleague’s main post that is reflective and justified with credible sources. |
|
9 pts | ||||
| This criterion is linked to a Learning OutcomeSecond Response:Writing |
|
6 pts | ||||
| This criterion is linked to a Learning OutcomeSecond Response:Timely and full participation |
|
5 pts | ||||
| Total Points: 100 | ||||||
